Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis

Gastroenterology

Volumn 150, Issue 5, 2016, Pages 1113-1124.e5

  Lee, Yi Chia ^a,b   Chiang, Tsung Hsien ^a,c   Chou, Chu Kuang ^a,d   Tu, Yu Kang ^b   Liao, Wei Chih ^a,b   Wu, Ming Shiang ^a,c   Graham, David Y ^e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antibiotic; Risk Factor; Stomach; Tumor

Indexed keywords

ARTICLE; BACTERIAL CLEARANCE; CANCER INCIDENCE; ENDOSCOPIC SURGERY; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION; STOMACH CANCER; SYSTEMATIC REVIEW; COMBINATION DRUG THERAPY; DRUG EFFECTS; HELICOBACTER INFECTIONS; INCIDENCE; MICROBIOLOGY; ODDS RATIO; PATHOGENICITY; PROTECTION; RISK ASSESSMENT; RISK FACTOR; STOMACH NEOPLASMS; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; ODDS RATIO; PROTECTIVE FACTORS; PROTON PUMP INHIBITORS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84964370106     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.01.028     Document Type: Article

References (56)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. W.K. Leung, M.S. Wu, Y. Kakugawa, and et al. Screening for gastric cancer in Asia: current evidence and practice Lancet Oncol 9 2008 279 287
3. F. Bray, A. Jemal, N. Grey, J. Ferlay, and D. Forman Global cancer transitions according to the Human Development Index (2008-2030): a population-based study Lancet Oncol 13 2012 790 801
4. IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Gastric Cancer Prevention. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No. 8). Available at: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php. Accessed on November 21, 2015.
5. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994 IARC Monogr Eval Carcinog Risks Hum 61 1994 1 241
6. C. de Martel, J. Ferlay, S. Franceschi, and et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 2012 607 615
7. P. Correa The biological model of gastric carcinogenesis IARC Sci Publ 2004 301 310
8. A.M. Machado, C. Figueiredo, E. Touati, and et al. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells Clin Cancer Res 15 2009 2995 3002
9. P. Malfertheiner, F. Megraud, C.A. O'Morain, and et al. Management of Helicobacter pylori infection - the Maastricht IV/ Florence Consensus Report Gut 61 2012 646 664
10. A.C. Ford, D. Forman, R.H. Hunt, Y. Yuan, and P. Moayyedi Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials BMJ 348 2014 g3174
11. B.C. Wong, S.K. Lam, W.M. Wong, and et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 291 2004 187 194
12. W.Q. Li, J.L. Ma, L. Zhang, and et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups J Natl Cancer Inst 2014 106
13. K. Fukase, M. Kato, S. Kikuchi, and et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 2008 392 397
14. R.H. Hunt, M. Camilleri, S.E. Crowe, and et al. The stomach in health and disease Gut 64 2015 1650 1668
15. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269 W64
16. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
17. S.Y. Kim, J.E. Park, Y.J. Lee, and et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity J Clin Epidemiol 66 2013 408 414
18. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
19. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
20. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
21. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
22. M.J. Sweeting, A.J. Sutton, and P.C. Lambert What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data Stat Med 23 2004 1351 1375
23. Y.K. Tu Use of generalized linear mixed models for network meta-analysis Med Decis Making 34 2014 911 918
24. S. Greenland Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis Epidemiology 6 1995 450 454
25. P. Correa, E.T. Fontham, J.C. Bravo, and et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy J Natl Cancer Inst 92 2000 1881 1888
26. D. Saito, N. Boku, T. Fujioka, and et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese Intervention Trial Gastroenterology 128 2005 A4
27. W.C. You, L.M. Brown, L. Zhang, and et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions J Natl Cancer Inst 98 2006 974 983
28. L. Zhou Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China Gastroenterology 134 2008 A233
29. B.C. Wong, L. Zhang, J.L. Ma, and et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions Gut 61 2012 812 818
30. K. Saito, K. Arai, M. Mori, and et al. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma Gastrointest Endosc 52 2000 27 32
31. S. Take, M. Mizuno, K. Ishiki, and et al. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases J Gastroenterol 42 Suppl 17 2007 21 27
32. R. Takenaka, H. Okada, J. Kato, and et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type Aliment Pharmacol Ther 25 2007 805 812
33. K. Ogura, Y. Hirata, A. Yanai, and et al. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer J Clin Gastroenterol 42 2008 279 283
34. K. Mabe, M. Takahashi, H. Oizumi, and et al. Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World J Gastroenterol 15 2009 4290 4297
35. K. Yanaoka, M. Oka, H. Ohata, and et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels Int J Cancer 125 2009 2697 2703
36. T.U. Kosunen, E. Pukkala, S. Sarna, and et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: a cohort study Int J Cancer 128 2011 433 439
37. Y.C. Lee, T.H. Chen, H.M. Chiu, and et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention Gut 62 2013 676 682
38. J. Choi, S.G. Kim, H. Yoon, and et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma Clin Gastroenterol Hepatol 12 2014 793 800
39. N. Uemura, T. Mukai, S. Okamoto, and et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer Cancer Epidemiol Biomarkers Prev 6 1997 639 642
40. S. Nakagawa, M. Asaka, M. Kato, and et al. Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer Aliment Pharmacol Ther 24 Suppl 4 2006 214 218
41. A. Shiotani, N. Uedo, H. Iishi, and et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication Digestion 78 2008 113 119
42. Y. Maehata, S. Nakamura, K. Fujisawa, and et al. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer Gastrointest Endosc 75 2012 39 46
43. J.Y. Seo, D.H. Lee, Y. Cho, and et al. Eradication of Helicobacter pylori reduces metachronous gastric cancer after endoscopic resection of early gastric cancer Hepatogastroenterology 60 2013 776 780
44. Y.H. Kwon, J. Heo, H.S. Lee, C.M. Cho, and S.W. Jeon Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients Aliment Pharmacol Ther 39 2014 609 618
45. S.E. Bae, H.Y. Jung, J. Kang, and et al. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm Am J Gastroenterol 109 2014 60 67
46. Y.I. Kim, I.J. Choi, M.C. Kook, and et al. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer Helicobacter 19 2014 194 201
47. L. Fuccio, R.M. Zagari, L.H. Eusebi, and et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151 2009 121 128
48. H.N. Chen, Z. Wang, X. Li, and et al. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis Gastric Cancer 19 2016 166 175
49. D.Y. Graham, and A. Shiotani The time to eradicate gastric cancer is now Gut 54 2005 735 738
50. D.Y. Graham Helicobacter pylori eradication and metachronous gastric cancer Clin Gastroenterol Hepatol 12 2014 801 803
51. A. Shiotani, K. Haruma, and D.Y. Graham Metachronous gastric cancer after successful Helicobacter pylori eradication World J Gastroenterol 20 2014 11552 11559
52. R. Herrero, J. Parsonnet, and E.R. Greenberg Prevention of gastric cancer JAMA 312 2014 1197 1198
53. D.Y. Graham, Y.C. Lee, and M.S. Wu Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence Clin Gastroenterol Hepatol 12 2014 177 186
54. K. Sugano, J. Tack, E.J. Kuipers, and et al. Kyoto global consensus report on Helicobacter pylori gastritis Gut 64 2015 1353 1367
55. M. Areia, R. Carvalho, A.T. Cadime, and et al. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies Helicobacter 18 2013 325 337
56. F. Bray, J.S. Ren, E. Masuyer, and et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008 Int J Cancer 132 2013 1133 1145